Many biotech watchers expect the hepatitis C market to follow a similar trajectory as the HIV drug market, where breakthrough first-generation drugs were relatively quickly supplanted by more convenient second-generation versions with fewer side effects.
The next major takeaway for me was that when I really needed to do something really quickly or was looking for that lightest weight and most convenient device, I reached for my smartphone .